Yüklüyor......
The role of factor Xa inhibitors in venous thromboembolism treatment
Three factor Xa inhibitors have been studied in the treatment of venous thromboembolism, both for acute therapy and as extended therapy to prevent recurrent events. Rivaroxaban, apixaban, and edoxaban have all proven to be effective in Phase III clinical trials for this indication when compared to c...
Kaydedildi:
| Yayımlandı: | Vasc Health Risk Manag |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4321604/ https://ncbi.nlm.nih.gov/pubmed/25673997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S39726 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|